Literature DB >> 15956596

Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+-T-cell escape variants of influenza virus.

Graeme E Price1, Lei Huang, Rong Ou, Menghua Zhang, Demetrius Moskophidis.   

Abstract

Antigenic variation is a viral strategy exploited to promote survival in the face of the host immune response and represents a major challenge for efficient vaccine development. Influenza viruses are pathogens with high transmissibility and mutation rates, enabling viral escape from immunity induced by prior infection or vaccination. Intense selection from neutralizing antibody drives antigenic changes in the surface glycoproteins, resulting in emergence of new strains able to reinfect hosts immune to previously circulating viruses. CD8+ cytotoxic T cells (CTLs) also provide protective immunity from influenza virus infection and may contribute to the antigenic evolution of influenza viruses. Utilizing mice transgenic for an influenza virus NP366-374 peptide-specific T-cell receptor, we demonstrated that the respiratory tract is a suitable site for generation of escape variants of influenza virus selected by CTL in vivo. In this report the contributions of the perforin and Fas pathways utilized by influenza virus-specific CTLs in viral clearance and selection of CTL escape variants have been evaluated. While transgenic CTLs deficient in either perforin- or Fas-mediated pathways are efficient in initial pulmonary viral control, variant virus emergence was observed in all the mice studied, although the spectrum of viral CTL escape variants selected varied profoundly. Thus, a less-restricted repertoire of escape variants was observed in mice with an intact perforin cytotoxic pathway compared with a limited variant diversity in perforin pathway-deficient mice, although maximal variant diversity was observed in mice having both Fas and perforin pathways intact. We conclude that selection of viral CTL escape variants reflects coordinate action between the tightly controlled perforin/granzyme pathway and the more promiscuous Fas/FasL pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956596      PMCID: PMC1143766          DOI: 10.1128/JVI.79.13.8545-8559.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Emergence of new influenza A viruses which carry an escape mutation of the HLA-B27-restricted CTL epitope of NP in Japan.

Authors:  T Kashiwagi; N Hamada; J Iwahashi; K Hara; T Ueda; H Noguchi; T Toyoda
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

Review 2.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Antigen-specific regulation of T cell-mediated cytokine production.

Authors:  M K Slifka; J L Whitton
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

4.  Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.

Authors:  A N Liu; A Z Mohammed; W R Rice; D T Fiedeldey; J S Liebermann; J A Whitsett; T J Braciale; R I Enelow
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

5.  Influenza--WHO cares.

Authors:  Klaus Stöhr
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

Review 6.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

7.  The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.

Authors:  G E Price; A Gaszewska-Mastarlarz; D Moskophidis
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

9.  Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.

Authors:  G E Price; R Ou; H Jiang; L Huang; D Moskophidis
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.

Authors:  B A Small; S A Dressel; C W Lawrence; D R Drake; M H Stoler; R I Enelow; T J Braciale
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  11 in total

1.  Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell.

Authors:  Gabrielle T Belz; Lei Zhang; Matthew D H Lay; Fiona Kupresanin; Miles P Davenport
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-30       Impact factor: 11.205

2.  Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles.

Authors:  Angela Pizzolla; Thi Ho Nguyen; Sneha Sant; Jade Jaffar; Tom Loudovaris; Stuart I Mannering; Paul G Thomas; Glen P Westall; Katherine Kedzierska; Linda M Wakim
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

3.  The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Memory CD4+ T cells: beyond "helper" functions.

Authors:  Kobporn Boonnak; Kanta Subbarao
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms.

Authors:  K Kai McKinstry; Tara M Strutt; Yi Kuang; Deborah M Brown; Stewert Sell; Richard W Dutton; Susan L Swain
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 6.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

Review 7.  Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus.

Authors:  Tara M Strutt; K Kai McKinstry; Nikki B Marshall; Allen M Vong; Richard W Dutton; Susan L Swain
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 8.  Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.

Authors:  Zuzana Staneková; Eva Varečková
Journal:  Virol J       Date:  2010-11-30       Impact factor: 4.099

9.  Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.

Authors:  Lei Huang; Lingqian Li; Kim D Klonowski; S Mark Tompkins; Ralph A Tripp; Andrew L Mellor
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  From virus to inflammation, how influenza promotes lung damage.

Authors:  Mitchell Klomp; Sumit Ghosh; Sohail Mohammed; M Nadeem Khan
Journal:  J Leukoc Biol       Date:  2020-09-08       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.